Active Shortage Capsule Oncology

Flurazepam Hydrochloride Cap · 1,500 days since initial FDA posting

Brand: FLURAZEPAM HYDROCHLORIDE

FDA lists Flurazepam Hydrochloride Cap as Active Shortage (Chartwell Molecular Holdings LLC).

Availability on file: Available

Flurazepam Hydrochloride Capsule: Active Shortage

Available Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Flurazepam Hydrochloride Capsule
Manufacturer
Chartwell Molecular Holdings LLC
Dosage Form
Capsule
Presentation
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)
Package NDC
62135-736-90

Status & Timeline

Status
Active Shortage
Availability
Available
First Reported
Aug 3, 2022
Last Updated
Feb 2, 2026
Therapeutic Category
Oncology, Other

Row fields from the FDA Drug Shortages database via openFDA.

Nearby, Other Flurazepam Shortage Records

Flurazepam Hydrochloride Capsule

Chartwell Molecular Holdings LLC

Capsule

Active Shortage

Flurazepam Hydrochloride Capsule

Chartwell Molecular Holdings LLC

Capsule

Active Shortage

Flurazepam Hydrochloride Capsule

Chartwell Molecular Holdings LLC

Capsule

Active Shortage

Flurazepam Hydrochloride Capsule

Rising Pharma Holdings, Inc.

Capsule

Active Shortage

Flurazepam Hydrochloride Capsule

Rising Pharma Holdings, Inc.

Capsule

Active Shortage
← All Drug Shortages